GO
Loading...

Depressed Pooch? Eli Lilly Gets FDA Approval for New Drug

CNBC.com
Wednesday, 25 Apr 2007 | 11:19 AM ET

Is your dog depressed? Having trouble letting you go in the morning? Help is on the way.

Eli Lilly said Wednesday it has received approval to market a chewable tablet that calms down dogs who misbehave when separated from their owners.

The Food and Drug Administration has approved Lilly's drug Reconcile to treat the estimated 10.7 million, or 17%, of U.S. dogs that have separation anxiety. According to a company release, dogs that exhibit separation anxiety are prone to "destruction, excess vocalization and inappropriate elimination."

Reconcile is part of a class of antidepressants known as selective serotonin reuptake inhibitors frequently marketed to humans. Lilly's blockbuster depression drug Prozac is one member of the class.

According to Lilly, 73% of dogs treated with the Reconcile showed improved behavior when separated from their owners compared with dogs receiving training alone.

  Price   Change %Change
LLY
---

Featured

Contact U.S. News

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    › Learn More

Don't Miss

U.S. Video

  • Markets then and now. Chuck Lieberman, Advisors Capital Management; Jim Awad, Plimsoll Mark Capital; Marshall Acuff, Silvercrest Asset Management; and Gene Peroni, Advisors Asset Management, discuss how the market has changed and evolved over the last 25 years.

  • Discussing whether Netflix is headed higher, with David Trainer, New Constructs CEO, and James Ramelli, KeeneOnTheMarket.com trader.

  • Former NBC Chairman Bob Wright discusses the market's adaption to new technology, and explains why the symbol for CNBC did not have the peacock at first.